ABSTRACT Adamantinoma is a rare, low-grade, malignant bone tumour. We report on a 46-year-old woman who had early multiple recurrences of adamantinoma of the right tibia and late metastasis to the lung and ribs 13 years after the first surgical treatment. She underwent multiple complete tumour excisions and eventually below-knee amputation and removal of the left lung and sixth to eighth ribs.
are noted in a bland fibrous stroma. 7 Adamantinoma is characterised by cytokeratin positivity and a clear epithelial differentiation of cell groups embedded in fibrous tissue. 8 Recurrence usually occurs late (even after 24 years 9 and 36 years 10 ), owing to slow development of the tumour. The recurrence rate is high (about 30%) after incomplete excision, and is reported to be 9% at 5 years and 18.6% at 10 years. 11 The metastasis rate is 10% to 20%, 3, 6 and lungs are most commonly affected. 1, 5 Adamantinoma is classified into 2 types: the classical, more-aggressive type and the differentiated, more-benign type. 1 The latter is of lower prevalence and affects mainly children younger than 10 years, 7 and resembles benign osteofibrous dysplasia. 6, 12, 13 This study reports a patient with early multiple recurrences of adamantinoma of the right tibia and late metastasis to the lung and ribs 13 years after the first surgical treatment.
case report
In October 2012, a 46-year-old woman presented with metastasis of adamantinoma of the right tibia 13 years after the initial surgical treatment. 17 years earlier, the patient had noticed dull pain in her right tibia. Radiography showed no evidence of bone pathology, and the patient was treated with pain-relief medications. One year later, she sustained a distal tibial fracture and underwent surgery elsewhere. Two years later, the pain in her tibia persisted, and she presented to our hospital. Radiographs revealed a multicystic, lytic, eccentric lesion in the cortex and medullary canal of the right tibial shaft (Fig. a) , but the patient declined surgery. Two years later, the patient underwent complete excision of the tumour, with a clean margin of 0.9 cm. In the following 6 years, the patient had 4 recurrences. She had the first recurrence one year after tumour excision and underwent more extensive excision (3.5x3x2 cm), with a clean margin of 0.8 cm. Six months later, she had the second recurrence and underwent complete excision, with a clean margin of 1.2 cm. Two years later, she had the third recurrence and underwent even more extensive excision (6x4x3 cm), with a clean margin of 2 cm. Three years later, the fourth recurrence in the distal tibia (Fig. b) was noted during distraction osteogenesis of the tibia. Owing to the aggressiveness of the tumour, a below-knee amputation was performed.
Computed tomography (CT) of the chest and abdomen performed every 18 months had not detected any metastasis. Seven years after the amputation, the patient presented with chest pain. CT of the chest revealed metastasis to the upper left lung and the sixth to eighth left ribs (Fig. c) . One month later, the patient underwent excision of the left lung and diseased ribs. Postoperative CT revealed no signs of topical or distal recurrences. Histologically, the excised tumour consisted of basaloid cells in a stroma of fibroconnective tissue. Tumour cells were semiround or atractoid, containing eosinophil cytosome and deep-coloured nuclei with continuous mitotic activity. Immunohistochemically, the tumour cells were vimentin and caldesmon positive cells, locally positive to pan-keratin (AE1/AE3) and to calponin and negative to actin of non-striated muscle, to desmin, to CD 117 (c kit), to epithelial membrane antigen, and to S-100. All surgical margins lacked tumour cells.
discussion
In our patient, the behaviour of the adamantinoma is inconsistent with its typical behaviour of slow development and non-aggressiveness. Despite the unusual early local recurrences, metastasis to lung and ribs occurred 13 years after the first surgery.
Histologically, the typical adamantinoma consists of clusters or nests of epithelial cells surrounded by spindle-cell fibrous tissue. 7, 14 There are 4 patterns for adamantinoma: basaloid, spindle cell, tubular, and squamous. 13 An Ewinglike adamantinoma with marked changes in histopathology has been reported. 15 In our patient, the adamantinoma of all recurrences consisted of basaloid cells, which also metastasised to the lung. The spindle cell variant is more commonly found in local recurrence and metastasis, and lung metastasis has been reported to consist only of keratin-positive epithelial cells without fibrous stromal tissue. 16 A dedifferentiated spindle-cell adamantinoma with very aggressive behaviour indicates that the tumour histology may not be related to its behaviour. Only the lack of squamous differentiation is correlated with an increased recurrence rate. 3 The low incidence of adamantinoma has precluded studies with enough power to establish any correlation between the histology type and the behaviour of the neoplasm.
Osteofibrous dysplasia is a differential diagnosis of or even associated with adamantinoma. 1 Osteofibrous dysplasia mostly occurs in the cortex of the tibia or fibula of infants and children younger than 10 years. 2 Multiple biopsies can monitor any change in the tumour status. 12 In radiographs, areas of eccentric cortical lucency and expansion present as focal lucent areas or as multiple 'bubble' areas. 17 Osteofibrous dysplasia tends not to progress and is a precursor of adamantinoma, including cell transformation from mesenchymal to epithelial features. 1, 18 In our patient, the adamantinoma developed without its osteofibrous dysplasia precursor lesion, and thus the diagnosis was missed initially. Adamantinoma is resistant to radiotherapy and chemotherapy 4 ; wide resection is recommended, 2, 5 followed by reconstruction to restore function. 4, 6, 19 conclusion Adamantinoma has a high rate of recurrence and metastasis. Early diagnosis enables early complete excision of the tumour. Frequent follow-up enables early detection of recurrence and metastasis.
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